NDC 72220-040-01 - MEDI PEEL CENTELLA MEZZO
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72220-040
- Requested NDC
- 72220-040-01
- Package NDCs from labels
- 72220-040-01, 72220-040-02
- Manufacturer
- Skinidea Co.,Ltd.
- Effective date
- 2018-04-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MEDI PEEL CENTELLA MEZZO - Skinidea Co.,Ltd. | Skinidea Co.,Ltd. | 2018-04-06 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tucks Triple Relief Hemorrhoidal | WHITE PETROLATUM, GLYCERIN, PRAMOXINE HYDROCHLORIDE, AND PHENYLEPHRINE HYDROCHLORIDE | Blistex Inc. | bf892e90-2d9b-4fa0-8ee4-8a2736be6c30 | 2024-12-24 | Warnings | PDC6A3C0OX |
| Pedia-Lax | GLYCERIN | C.B. Fleet Company, Inc. | 4e15f6ca-a40c-485f-be3f-07c2ed7cb498 | 2024-12-23 | Warnings | PDC6A3C0OX |
| OASIS Tears Preservative-Free Lubricant Eye | GLYCERIN | OASIS Medical, Inc. | d9d71b1d-82a6-42e7-9ef2-2d041daef936 | 2024-12-23 | Warnings | PDC6A3C0OX |
| DCH Hemorrhoidal | GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25% | Derma Care Research Labs, LLC | 0050701f-4393-3f01-e063-6394a90a4e0e | 2024-12-19 | Warnings | PDC6A3C0OX |
| Revivol Hemorrhoid and Fissure | GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25% | Derma Care Research Labs, LLC | 0140cf68-b6a0-4378-e063-6394a90afee8 | 2024-12-19 | Warnings | PDC6A3C0OX |
| RECTICARE | LIDOCAINE AND GLYCERIN | Ferndale Laboratories, Inc. | 2b94136a-4975-2925-e054-00144ff88e88 | 2024-12-17 | Warnings | PDC6A3C0OX |
| Adenosine | ADENOSINE | Medical Purchasing Solutions, LLC | 296af833-5724-3e23-e063-6394a90a6251 | 2024-12-16 | Warnings, Adverse reactions | K72T3FS567 |
| adenosine | ADENOSINE | Sagent Pharmaceuticals | 5a55b45d-9cee-4c0c-9e44-021dbf70a018 | 2024-12-04 | Warnings, Adverse reactions | K72T3FS567 |
| Burts Bees Rapid Rescue Cold Sore Treatment | CAMPHOR, GLYCERIN | Burts Bees | 9f89735d-205f-4d3e-a1e1-ecc96284fe98 | 2024-12-03 | Warnings | PDC6A3C0OX |
| Ventrixyl | FOLIC ACID | PureTek Corporation | c29dc729-93be-2a20-e053-2a95a90a8ca3 | 2024-12-03 | Warnings, Adverse reactions | 25X51I8RD4 |
| Folitin-Z | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | bb141ac2-e5df-4df4-e053-2995a90a6e72 | 2024-12-02 | Warnings, Adverse reactions | 25X51I8RD4 |
| Davimet with Iron | IRON, FOLATE | PureTek Corporation | 1445921b-5bf4-ea48-e063-6294a90abb1a | 2024-11-27 | Warnings, Adverse reactions | 25X51I8RD4 |
| Foliflex | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | cba98d1a-8cf9-39d9-e053-2995a90ae8bb | 2024-11-27 | Warnings, Adverse reactions | 25X51I8RD4 |
| Tissen ICM 10 | ADENOSINE | Dalim Tissen | a2f648e2-0f8e-4635-9169-3185e8fbeb92 | 2024-11-25 | Warnings | K72T3FS567 |
| Tissen NF 10 | ADENOSINE | Dalim Tissen | 0c71d3f0-949d-4c00-8758-4ae7c9fd11ed | 2024-11-25 | Warnings | K72T3FS567 |
| Finazol | FERROUS FUMARATE, FOLATE | PureTek Corporation | 24290823-022a-433b-e063-6394a90a8fd0 | 2024-11-07 | Warnings, Adverse reactions | 25X51I8RD4 |
| Stratuscare Adult Glycerin | GLYCERIN | Stratus Pharmaceuticals | 3e1935da-5c1f-4942-98dd-320fade82321 | 2024-11-04 | Warnings | PDC6A3C0OX |
| Stratuscare Glycerin Laxative Pediatric | GLYCERIN | Stratus Pharmaceuticals | 6ae6d3c4-bb3b-4436-b76d-8654bf871e66 | 2024-11-01 | Warnings | PDC6A3C0OX |
| Clear Eyes Cooling Redness Relief | GLYCERIN AND NAPHAZOLINE HYDROCHLORIDE | Prestige Brands Holdings, Inc. | 38d14e99-e4c8-431b-b106-578eeb38bf3c | 2024-10-25 | Warnings | PDC6A3C0OX |
| Pedia-Lax | GLYCERIN | C.B. Fleet Company, Inc. | ae367381-7146-4307-823d-2bb44c1d4200 | 2024-10-25 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.